Skip navigation

A Forum for Emerging and Innovative Pharma, Biotech and Device Companies

October 17-18, 2017
  • San Francisco, CA

The industry’s “go-to” event for innovative and emerging bio/pharmaceutical and medical device manufacturers ramps up for the most in-depth and impactful year yet.

Backed by 8 years of high-quality content, CBI’s
Life Sciences Compliance Congress West continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre-launch to commercial, within life sciences.

Spotlight Session graphic

Can’t Miss Content for Local CCOs and their Counterparts:

  • Top enforcement trends and focal points for 2018 and beyond
  • Analyze and assess new and emerging city and state ordinances
  • Examine the new draft guidance documents released January 2017 “Medical Product Communications That Are Consistent With the
    FDA-Required Labeling”
    “Drug and Device Manufacturer Communications with Payors,
    Formulary Committees and Similar Entities”
  • Optimize HCP engagement and contracting
  • Discuss how life sciences companies need to prepare for the
    May 25, 2018 GDPR deadline in order to remain compliant and
    garner insight on how this regulation differs from HIPAA
  • Navigate the complexities of PAPs, reimbursement and
    patient support compliance
  • Assess speaker programs and the continued rise of kickback allegations
  • Utilize monitoring data and analytics for meaningful metrics
Validated by Your Counterparts in Compliance:
attendance infographic